China has included four COVID-19 vaccines that have been granted conditional market approval domestically in a list of vaccine products available for export. The four vaccines are manufactured by Beijing Institute of Biological Products Co Ltd, Sinovac Life Sciences Co Ltd, CanSino Biologics Inc and...
approvedGENEVA,June 1(Xinhua)鈥揟he World Health Organization(WHO),on June 1,validated the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac for emergency use.At the WHO press conference,Director-General Tedros Adhanom Ghebreyesus announced that the Sinovac-CoronaVac ...
According to the World Health Organization (WHO), nine out of 300 vaccine candidates worldwide are in phase-3 human trials. Four of those are being produced in China by Sinovac Biotech, private firm CanSino Biologics, state-owned Sinopharm Group, and China National Biotec, which is a part ...
WASHINGTON, May 27 (Xinhua) -- The results of China's COVID-19 vaccine trial, the first such vaccine to reach phase 1 clinical trial, are "very impressive," a leading U.S. epidemiologist told Xinhua in a recent interview. China's vaccine trial has been found to be safe, well-tolerate...
The COVID-19 vaccine developed by China's Sinopharm has been approved by the World Health Organization (WHO) for "emergency use." This means its safety, efficacy and quality has been checked and it can be used by the international COVAX vaccine effort. WHO Director-General Tedros...
Addressing a regular press briefing, Hua reiterated China's opposition to "vaccine nationalism" as well as irresponsible and unethical behaviors that create "immunity gap." She urged capable countries to provide vaccines to other countries in need, especially developing countries, s...
China will provide COVID-19 vaccines for free to the Chinese public as the first vaccine has been granted conditional marketing approval for the general population, said Zeng Yixin, deputy director of the National Health Commission, at a press conference on Thursday. ...
China approves first Recombinant Protein-based COVID-19 Vaccine｜我国首个国产重组新冠病毒蛋白疫苗获批上市 China National Medical Products Administration (NMPA) on Tuesday conditionally approved the application for listing registration of a Recombinant Protein-based COVID-19 Vaccine (CHO Cells) developed by...
BEIJING, May 8 (Xinhua) -- A joint Chinese research team has recently published the results of the first animal experiment of one COVID-19 vaccine candidate in the journal Science. A purified inactivated COVID-19 vaccine candidate (PiCoVacc) confers complete protection in non-human primates ag...
The first batch of COVID-19 vaccines donated by the Chinese government arrived in Port Vila, the capital of Vanuatu on Monday. The Sinopharm COVID-19 vaccines, transported via Air Vanuatu's charter flight, are the first bilateral vaccine donation the pacific island country has rec...